Gynesonics Logo.jpg
Gynesonics Announces New SMART OS™ Software Technology for Sonata® System Treatment of Uterine Fibroids
26 sept. 2024 08h30 HE | Gynesonics
REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids,...
Gynesonics Logo.jpg
Gynesonics® Reaches Milestone with 10,000th Patient Treatment with Sonata System
20 août 2024 10h30 HE | Gynesonics
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for...
Ted-Stephens-300x300
Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
19 mars 2024 10h00 HE | Gynesonics
Gynesonics announces key executive appointments to further accelerate and expand adoption of the Sonata Treatment.
Gynesonics Logo.jpg
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
02 janv. 2024 11h13 HE | Gynesonics
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
Gynesonics Logo.jpg
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
02 nov. 2023 09h41 HE | Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
Gynesonics Logo.jpg
CORRECTION – Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
01 nov. 2023 20h08 HE | Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
Gynesonics Logo.jpg
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
01 nov. 2023 16h00 HE | Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
Gynesonics Logo.jpg
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestones in the U.S. and Globally
25 oct. 2023 16h07 HE | Gynesonics
Gynesonics is pleased to announce that its Sonata Procedure has been used to treat over 1,000 women in the United States in 2023
Gynesonics Logo.jpg
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestones in the U.S. and Globally
17 oct. 2023 12h00 HE | Gynesonics
Gynesonics' Sonata® Procedure has been used to treat over 1,000 women in the United States and approximately 6,500 women globally.
Gynesonics Logo.jpg
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids is Now Covered by UnitedHealthcare
01 août 2023 15h02 HE | Gynesonics
REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is...